← brief for 2026-08-26 · Slowing decline

Translational advances in diabetic nephropathy management: integrating nanoformulation-based drug delivery systems

Key takeaways

This is a review of tiny particle drug carriers, called nanoformulations, for kidney damage caused by diabetes. The idea is to pack a drug inside a very small carrier so more of it reaches the kidney and less spreads through the body. The authors summarize lab work done by other groups and run no study of their own. There are no results in people here.

Who did this work

Mohd Danish Ansari (University of Malaya) · Ashish Vishwakarma (Delhi Pharmaceutical Science and Research University) · Md Quamuddin (Metro Health Hospital) · Mansi Aggarwal (Kumoh National Institute of Technology) · Hashim Khan (Metro Health Hospital) · Muhammad Fauzi Abd Jalil (University of Malaya) · Syed Mahmood (University of Malaya) · Adil Farooq Wali (Ras al-Khaimah Medical and Health Sciences University) · Sirajunisa Talath (Ras al-Khaimah Medical and Health Sciences University) · Mohamed El-Tanani (Ras al-Khaimah Medical and Health Sciences University)

Source

Paper · OpenAlex, CKD works · 2026-08-25
https://doi.org/10.3389/fmedt.2026.1951734